Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study

MYOCARDITIS RESPONSE TO COLCHICINE THERAPY BASED ON CARDIAC MRI DIAGNOSTIC CRITERIA

(2021) Omid Behbahani-Nejad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myocarditis after Covid-19 mRNA Vaccination

(2021) Amanda K. Verma et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

(2021) Julia W. Gargano et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination

(2021) Dongngan T. Truong et al.   CIRCULATION

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation

(2018) Vanessa M. Ferreira et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence

(2016) Antonio Brucato et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)

(2010) Antonio Abbate et al.   AMERICAN JOURNAL OF CARDIOLOGY